Hyperparameter optimization using custom genetic algorithm for classification of benign and malicious traffic on internet of things–23 dataset von Thavasimani, Karthikayini, Kasturirangan Srinath, Nuggehalli

Volltext

Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodies von Aertker, Kristina M J, Pilvankar, Minu Ravindra, Prass, Tobias M, Blech, Michaela, Higel, Fabian, Kasturirangan, Srinath

Volltext

An adapted consensus protein design strategy for identifying globally optimal biotherapeutics von Liu, Yanyun, Tsang, Kenny, Mays, Michelle, Hansen, Gale, Chiecko, Jeffrey, Crames, Maureen, Wei, Yangjie, Zhou, Weijie, Fredrick, Chase, Hu, James, Liu, Dongmei, Gebhard, Douglas, Huang, Zhong-Fu, Datar, Akshita, Kronkaitis, Anthony, Gueneva-Boucheva, Kristina, Seeliger, Daniel, Han, Fei, Sen, Saurabh, Kasturirangan, Srinath, Scheer, Justin M, Nixon, Andrew E, Panavas, Tadas, Marlow, Michael S, Kumar, Sandeep

Volltext

The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics von Devanaboyina, Siva Charan, Lynch, Sandra M, Ober, Raimund J, Ram, Sripad, Kim, Dongyoung, Puig-Canto, Alberto, Breen, Shannon, Kasturirangan, Srinath, Fowler, Susan, Peng, Li, Zhong, Haihong, Jermutus, Lutz, Wu, Herren, Webster, Carl, Ward, E Sally, Gao, Changshou

Volltext

Characterization of a Novel Bispecific Antibody With Improved Conformational and Chemical Stability von Manikwar, Prakash, Mulagapati, Sri Hari Raju, Kasturirangan, Srinath, Moez, Khashayar, Rainey, Godfrey Jonah, Lobo, Brian

Volltext

Detecting Morphologically Distinct Oligomeric Forms of α-Synuclein von Emadi, Sharareh, Kasturirangan, Srinath, Wang, Min S., Schulz, Philip, Sierks, Michael R.

Volltext

CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease von Sierks, Michael R, Chatterjee, Gaurav, McGraw, Claire, Kasturirangan, Srinath, Schulz, Philip, Prasad, Shalini

Volltext

Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody von Kasturirangan, Srinath, Rainey, G. Jonah, Xu, Linda, Wang, Xinwei, Portnoff, Alyse, Chen, Tracy, Fazenbaker, Christine, Zhong, Helen, Bee, Jared, Zeng, Zhutian, Jenne, Craig, Wu, Herren, Gao, Changshou

Volltext

Nanobody specific for oligomeric beta-amyloid stabilizes nontoxic form von Kasturirangan, Srinath, Li, Lin, Emadi, Sharareh, Boddapati, Shanta, Schulz, Philip, Sierks, Michael R

Volltext

Anti-oligomeric Aβ Single-chain Variable Domain Antibody Blocks Aβ-induced Toxicity Against Human Neuroblastoma Cells von Zameer, Andleeb, Kasturirangan, Srinath, Emadi, Sharareh, Nimmagadda, Sridevi V., Sierks, Michael R.

Volltext

A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer von Jung, Peter, Glaser, Stefan P, Han, Jing, Popa, Alexandra, Pisarsky, Laura, Feng, Ningping, Geyer, Antonia, Haderk, Franziska, Alpar, Donat, Bristow, Christopher, Schmittner, Susanne, Traexler, Paula-Elena, Mahendra, Mikhila, Poehn, Birgit, Gandhi, Poojabahen, Fiorelli, Roberto, Awate, Sanket, Budano, Nicole, Martin, Florian, Albrecht, Christoph, Drobits-Handl, Barbara, Anand, Sathanandam S, Kasturirangan, Srinath, Trapani, Francesca, Schweifer, Norbert, Marszalek, Joseph R, Tontsch-Grunt, Ulrike, Pearson, Mark, Heffernan, Timothy P, Kraut, Norbert, Vellano, Christopher P, García-Martínez, Juan Manuel

Volltext

Engineered Proteolytic Nanobodies Reduce Aβ Burden and Ameliorate Aβ-Induced Cytotoxicity von Kasturirangan, Srinath, Boddapati, Shanta, Sierks, Michael R

Volltext

Abstract 2775: A novel immunostimulatory OX40/PD-L1 bivalent bispecific antibody (MEDI1109) for the treatment of patients with cancer von Oberst, Michael D., Kasturirangan, Srinath, Sachs, Clifford, Auge, Catherine, Moynihan, James, Rothstein, Raymond, Hair, James, Neal, Francis, Mamidi, Srinivas, Hanabuchi, Shino, Watkins, Amanda, Zheng, Yanan, Rosenthal, Kim, Freeman, Daniel J., Hammond, Scott

Volltext

Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples von Kasturirangan, Srinath, Reasoner, Tim, Schulz, Philip, Boddapati, Shanta, Emadi, Sharareh, Valla, Jon, Sierks, Michael R.

Volltext

Promoting α-secretase cleavage of beta-amyloid with engineered proteolytic antibody fragments von Kasturirangan, Srinath, Brune, Dan, Sierks, Michael

Volltext

P2-335: Supplementing α-secretase cleavage of beta-amyloid by targeted proteolytic antibody fragments using yeast display technology von Kasturirangan, Srinath, Sierks, Mike

Volltext

Detecting Morphologically Distinct Oligomeric Forms of {alpha}-Synuclein von Emadi, Sharareh, Kasturirangan, Srinath, Wang, Min S, Schulz, Philip, Sierks, Michael R

Volltext

Detecting Morphologically Distinct Oligomeric Forms of α-Synuclein von Sharareh Emadi, Srinath Kasturirangan, Min S. Wang, Philip Schulz, Michael R. Sierks

Volltext

Engineered proteolytic nanobodies reduce Abeta burden and ameliorate Abeta-induced cytotoxicity von Kasturirangan, Srinath, Boddapati, Shanta, Sierks, Michael R

Volltext

ANTIBODY BASED REAGENT THAT SPECIFICALLY RECOGNIZES TOXIC OLIGOMERIC FORM OF BETA-AMYLOID von Kasturirangan, Srinath, Sierks, Michael

Volltext bestellen